2nd Bioengineering & Translational Medicine Conference

Session: Immunoengineering

Presentations

01:00 PM

Vignettes on Engineering Targeted, Immunomodulatory Therapies
Look, M.

01:30 PM

Inhibition of Cancer Immune Suppression with a First-in-Class Engineered Therapeutic Enzyme
Blazeck, J., Triplett, T., Stone, E., Georgiou, G., Karamitros, C., Garrison, K.

01:45 PM

Engineering Robust T Cells for Cancer Immunotherapy
Chen, Y. Y.

02:00 PM

Quantitative In Vivo & Ex Vivo Multimodality Cell Imaging of Antigen-Specific T-Cells in Murine Metastatic Ovarian Cancer
Willadsen, M., Yarovoy, I., Zhang, A. Q., Turowski, S., Spernyak, J., Seshadri, M., McGray, A. J. R., Odunsi, K., Parashurama, N.

02:15 PM

Single-Cell Profiling Demonstrates That Migratory T Cells Demonstrate Superior Persistence and Enhanced Tumor Control
Varadarajan, N.

02:30 PM

Engineering Nanotechnologies for Immuno-Oncology: "Smart" Nanoparticles for Immunotherapeutic Targeting of the Sting Pathway
Shae, D., Wilson, J. T., Sevimli, S.

02:45 PM

Direct Selection of Synthetic Binding Proteins That Recognize Post-Translationally Modified Proteins in Living Cells
Meksiriporn, B., DeLisa, M., Jiang, A., Waraho, D., Lee, H. C.

03:00 PM

Utilizing Oxygen-Inhibited Photopolymerization to Control Size of Multimodal PEGDA Hydrogel Nanoparticles for Cancer Therapeutics
Debroy, D., Li, D., Oakey, J.